According to recent media reports, Chinese police have wrapped up their probe into allegations of bribery involving drug maker GlaxoSmithKline's (GSK's) China operations, and are ready to hand over their findings to prosecutors. These reports go on to mention that, in some extreme cases, GSK drugs are sold in China at prices up to seven times higher than in other markets.

GSK is not the only multinational company that has a radically different pricing strategy in China relative to other markets. Most foreign automobiles, for instance, sell at much higher prices in China than elsewhere. But even though Chinese consumers spend more, they often receive inferior service compared to overseas shoppers buying the same goods.

Ordinary consumers have long embraced large foreign brands and products. Government officials too have offered preferential policies to entice international businesses to set up manufacturing centers in China. Chinese consumers should be given the same service as consumers in other markets; and the Chinese government should establish a fair and transparent market for all enterprises, regardless of their country of origin.

The author is Yao Qian, a media personality.